(精编)【持续性肾脏替代治疗CRRT英文精品课件】Renal Replacement Therapy(63p).pptVIP

Renal Replacement Therapy;Criteria for diagnosis of acute renal failure;Investigations that may help to differentiate renal hypoperfusion from acute renal failure in oliguric patients ;Relationship between Serum Creatinine and GFR;Guidelines for immediate management of patients with oliguria or anuria ;The cause of acidosis will determine the treatment ;Indications for starting RRT;Indications II;Indications III;Modes of RRT;Haemodialysis;Haemodialysis;Peritoneal Dialysis;Haemofiltration;ULTRAFILTRATION: The movement of fluid through a membrane caused by a pressure gradient.;Haemofiltration;Continuous Veno-venous Haemofiltration;Haemodialysis;Solute Clearance;Diffusive Solute Clearance;Diffusive Solute Clearance;HEMODIALYSISDiffusion;Haemodiafiltration;Prisma Haemodiafiltration;Advantages of using CRRT;Disadvantages of using CRRT;Setting up and using CRRT;Vascular Access;“Dose” of RRT;Anticoagulation for RRT;Site of Action of Anticoagulants;Unfractionated Heparin;Low Molecular Weight Heparin;Heparin Induced Thrombocytopoenia;Prostacycline;Citrate;;Xigris;No Anticoagulant;Monitoring RRT;Monitoring Urine output;Key points ;SGH Guidelines for RRT;Type of replacement fluid ;Priming the circuit;How long should filters last ;Blood testing ;Blood Testing;Who and by how much to anticoagulate;Who and by how much to anticoagulate;Who and by how much to anticoagulate;GROUP 1 - Patient at moderate risk of bleeding;GROUP 2 - Patients at low risk of bleeding or where standard approach results in poor filter life;GROUP 3 - Patient at high risk of bleeding;GROUP 3 - Patient at high risk of bleeding;Epoprostenol [Flolan] ;Guidelines for heparin dose alteration;;;Renal Replacement Therapy Key Points